Pivotal bioVenture Partners Investment Advisor LLC
Source: SEC Form 13F · as of Mar 2026Pivotal bioVenture Partners Investment Advisor LLC holds 12 biotech & pharma companies tracked by BioSniper, totaling $279.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$279.6M
| Company | Shares | Value |
|---|---|---|
| PCVXVaxcyte, Inc. | 1,372,425 | $79.8M |
| OCSOculis Holding AG | 1,680,283 | $44.7M |
| EVMNEvommune, Inc. | 1,926,943 | $44.3M |
| ARQTArcutis Biotherapeutics, Inc. | 1,355,892 | $31.9M |
| TRVITrevi Therapeutics, Inc. | 1,553,726 | $18.5M |
| IMNMImmunome Inc. | 732,512 | $16.0M |
| MPLTMapLight Therapeutics, Inc. | 611,447 | $12.4M |
| ZBIOZenas BioPharma, Inc. | 591,991 | $11.6M |
| BIOABioAge Labs, Inc. | 653,374 | $11.4M |
| AVTXAvalo Therapeutics, Inc. | 295,933 | $4.4M |
| RLYBRallybio Corp | 300,579 | $2.7M |
| RXRXRECURSION PHARMACEUTICALS, INC. | 595,518 | $1.8M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.